Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Kramer

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Orthopaedics|January 9, 2016
The use of traction for treating femoral shaft fractures in low- and middle-income countries: a systematic reviewErik James Kramer, David Shearer, Saam Morshed
Protein Engineering, Design & Selection : PEDS|June 28, 2005
Computational modeling of type I collagen fibers to determine the extracellular matrix structure of connective tissuesMeir Israelowitz, Syed W H Rizvi, James Kramer, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|October 22, 2020
A Randomized Study Using Telepresence Robots for Behavioral Health in Interprofessional Practice and EducationJohn Rosasco, Zachary Hanson, James Kramer, et al.
Scientific Reports|December 1, 2015
Quantitative Profiling of the Effects of Vanoxerine on Human Cardiac Ion Channels and its Application to Cardiac RiskCarlos A Obejero-Paz, Andrew Bruening-Wright, James Kramer, et al.
Scientific Reports|July 2, 2013
MICE models: superior to the HERG model in predicting Torsade de PointesJames Kramer, Carlos A Obejero-Paz, Glenn Myatt, et al.
Biomed Research International|August 25, 2015
Three-Dimensional Modelling inside a Differential Pressure Laminar Flow Bioreactor Filled with Porous MediaBirgit Weyand, Meir Israelowitz, James Kramer, et al.
Clinical Pharmacology and Therapeutics|August 29, 2018
Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA InitiativeZhihua Li, Bradley J Ridder, Xiaomei Han, et al.
Clinical and Translational Science|February 23, 2021
Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off-label in the first wave of COVID-19Annie Delaunois, Matthew Abernathy, Warren D Anderson, et al.
Journal of Pharmacological and Toxicological Methods|June 24, 2020
A general procedure to select calibration drugs for lab-specific validation and calibration of proarrhythmia risk prediction models: An illustrative example using the CiPA modelXiaomei Han, Mohammadreza Samieegohar, Bradley J Ridder, et al.
Journal of Biomolecular Screening|July 15, 2015
A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay ParadigmBernard Fermini, Jules C Hancox, Najah Abi-Gerges, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Orthopaedics|January 9, 2016
The use of traction for treating femoral shaft fractures in low- and middle-income countries: a systematic reviewErik James Kramer, David Shearer, Saam Morshed
Protein Engineering, Design & Selection : PEDS|June 28, 2005
Computational modeling of type I collagen fibers to determine the extracellular matrix structure of connective tissuesMeir Israelowitz, Syed W H Rizvi, James Kramer, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|October 22, 2020
A Randomized Study Using Telepresence Robots for Behavioral Health in Interprofessional Practice and EducationJohn Rosasco, Zachary Hanson, James Kramer, et al.
Scientific Reports|December 1, 2015
Quantitative Profiling of the Effects of Vanoxerine on Human Cardiac Ion Channels and its Application to Cardiac RiskCarlos A Obejero-Paz, Andrew Bruening-Wright, James Kramer, et al.
Scientific Reports|July 2, 2013
MICE models: superior to the HERG model in predicting Torsade de PointesJames Kramer, Carlos A Obejero-Paz, Glenn Myatt, et al.
Biomed Research International|August 25, 2015
Three-Dimensional Modelling inside a Differential Pressure Laminar Flow Bioreactor Filled with Porous MediaBirgit Weyand, Meir Israelowitz, James Kramer, et al.
Clinical Pharmacology and Therapeutics|August 29, 2018
Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA InitiativeZhihua Li, Bradley J Ridder, Xiaomei Han, et al.
Clinical and Translational Science|February 23, 2021
Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off-label in the first wave of COVID-19Annie Delaunois, Matthew Abernathy, Warren D Anderson, et al.
Journal of Pharmacological and Toxicological Methods|June 24, 2020
A general procedure to select calibration drugs for lab-specific validation and calibration of proarrhythmia risk prediction models: An illustrative example using the CiPA modelXiaomei Han, Mohammadreza Samieegohar, Bradley J Ridder, et al.
Journal of Biomolecular Screening|July 15, 2015
A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay ParadigmBernard Fermini, Jules C Hancox, Najah Abi-Gerges, et al.
Pageof 2